The forecast for modulators of the genital system and sex hormones sales in Canada shows a consistent decline from 2024 to 2028. Starting in 2024 with 1.7% of total sales, it drops steadily each year, reaching 1.2% by 2028. This pattern suggests a decrease in market share, with a year-on-year decline in the percentage of total sales. Although the specific value for 2023 is unavailable, the downward trend from 2024 onward is evident. Over the five-year period, the compound annual growth rate (CAGR) reflects this negative trajectory.

Future trends to watch for include:

Changes in healthcare regulations and policies that might affect market dynamics.
Innovations or new product launches that could influence market recovery.
Demographic or lifestyle changes impacting demand for these products.